Zai Lab Limited
ZLAB
$19.52
-$0.36-1.81%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 13.70% | 49.27% | 9.41% | 14.40% | 39.74% |
| Total Depreciation and Amortization | 35.88% | 27.00% | 14.81% | 23.30% | 49.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 163.63% | -53.42% | 8.24% | 624.25% | -76.92% |
| Change in Net Operating Assets | -255.94% | -2,791.41% | 38.90% | -126.49% | 204.04% |
| Cash from Operations | -19.47% | 26.44% | 31.53% | -273.86% | 51.47% |
| Capital Expenditure | -123.92% | -289.34% | -57.49% | -1,071.17% | 23.58% |
| Sale of Property, Plant, and Equipment | -- | 65.52% | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 96.21% | 36.57% | 7,580.90% | -2,451.35% | -133.29% |
| Cash from Investing | 86.45% | -245.39% | 9,806.83% | -2,505.44% | -113.75% |
| Total Debt Issued | 48.54% | 0.81% | 111.18% | -- | -- |
| Total Debt Repaid | -12,000.35% | -- | -- | -- | -- |
| Issuance of Common Stock | 55.21% | 19,070.45% | -- | 46,544.47% | 832.12% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -22.00% | -- | -- |
| Cash from Financing | -50.74% | -60.36% | -9.27% | 60,411.96% | 3,016.86% |
| Foreign Exchange rate Adjustments | -65.49% | 418.18% | 119.23% | -197.14% | 53.13% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.27% | -20.56% | 881.29% | -25,088.44% | 80.16% |